D-Mannose

Background 

D-Mannose is a naturally occurring simple sugar that is closely related to glucose. It is found in small amounts in fruits and vegetables, including cranberries, apples, oranges, peaches, and broccoli, and the body can also produce small amounts naturally. 

Unlike glucose, D-Mannose is not extensively metabolized for energy. After it is absorbed, much of it is filtered by the kidneys and excreted through the urine. This unique pathway allows D-Mannose to reach the urinary tract, where it has been studied for its ability to support a healthy urinary environment and the body's natural urinary cleansing processes. 

Traditional Uses 

Foods naturally containing D-Mannose, particularly cranberries, have a long history of use for supporting bladder and urinary tract wellness. While D-Mannose itself was not historically isolated and used as a traditional remedy, modern research has helped identify its unique role in urinary health. 

Today, D-Mannose is commonly used as a targeted nutritional supplement for maintaining bladder and urinary tract wellness. It is particularly popular among women looking for ongoing support for urinary comfort and the body's natural ability to keep the urinary tract clean and balanced. 

What Does Science Tell Us? 

Much of the scientific interest in D-Mannose centers on its interaction with certain strains of Escherichia coli (E. coli), a type of bacteria commonly associated with urinary tract concerns. These bacteria have tiny hair-like structures called type 1 fimbriae that allow them to attach to mannose-containing receptors on cells lining the urinary tract. 

D-Mannose can interact with these fimbriae, potentially making it more difficult for certain bacteria to adhere to the urinary tract lining. Because D-Mannose is excreted through the urine, bacteria interacting with it may then be more readily carried away during normal urination. This provides a unique mechanism for supporting the body's natural urinary cleansing processes without directly killing bacteria. 

Clinical studies have investigated D-Mannose for maintaining urinary tract health, particularly among women who experience recurrent urinary concerns. Some earlier trials reported encouraging results, including reductions in recurrence. However, a large randomized, placebo-controlled clinical trial published in 2024 did not find that daily D-Mannose significantly reduced medically attended recurrent urinary tract infections compared with placebo. 

Taken together, the research supports a biologically plausible mechanism for D-Mannose in urinary tract wellness, but clinical evidence for preventing recurrent UTIs remains mixed. D-Mannose is best positioned as nutritional support for a healthy urinary environment rather than as a treatment or proven preventive measure for urinary tract infections. 

Safety 

D-Mannose is generally well tolerated when used as directed. Because only a relatively small amount is metabolized by the body, much of an ingested dose is eliminated through the urine. 

The most commonly reported side effects are mild gastrointestinal symptoms, including bloating, loose stools, or diarrhea, particularly at higher amounts. 

D-Mannose should not be used as a substitute for appropriate medical care when a urinary tract infection is suspected. Symptoms such as fever, chills, back or side pain, blood in the urine, or persistent urinary discomfort should be evaluated by a healthcare professional. 

Individuals who are pregnant, nursing, taking medications, or managing a medical condition should consult a healthcare professional before beginning supplementation. 

References 

1. Hayward G, Mort S, Hay AD, et al. D-Mannose for prevention of recurrent urinary tract infection among women: A randomized clinical trial. JAMA Internal Medicine. 2024;184(6):619-628. 
2. Kranjčec B, Papeš D, Altarac S. D-Mannose powder for prophylaxis of recurrent urinary tract infections in women: A randomized clinical trial. World Journal of Urology. 2014;32(1):79-84. 
3. Lenger SM, Bradley MS, Thomas DA, Bertolet MH, Lowder JL, Sutcliffe S. D-Mannose vs other agents for recurrent urinary tract infection prevention in adult women: A systematic review and meta-analysis. American Journal of Obstetrics & Gynecology. 2020;223(2):265.e1-265.e13. 
4. Domenici L, Monti M, Bracchi C, et al. D-Mannose: A promising support for acute urinary tract infections in women. A pilot study. European Review for Medical and Pharmacological Sciences. 2016;20(13):2920-2925.